We have identified a new type of A alpha Gly-17 to Val substitution in a congenital dysfibrinogen,
fibrinogen Bremen, derived from a 15-year-old boy having manifested easy bruising and delayed wound healing. The functional abnormality was characterized by altered
fibrin monomer polymerization, which became evident by increasing the
salt concentration and pH. A synthetic tetrapeptide with a sequence of the amino-terminal segment of normal
fibrin alpha-chain,
Gly-Pro-Arg-Val, substantially inhibited polymerization of both normal and the patient-derived
fibrin monomers. A synthetic tetrapeptide with the Bremen type sequence of Val-
Pro-Arg-Val inhibited polymerization of the patient's
fibrin monomers partially at a
peptide:
fibrin monomer molar ratio of 4,000:1, and that of normal one at a much higher ratio of 10,000:1. Likewise, a synthetic
peptide Ala-Pro-
Arg-Val with a replacement of the Gly residue by another aliphatic
amino acid Ala inhibited similarly the patient's
fibrin monomer polymerization. Thus, the hypothetical two-pronged socket-like structure consisting of the alpha-amino group of the amino-terminal Gly and the guanidino group of an Arg at position 3 of the normal
fibrin alpha-chain seems to be restored considerably in the mutant
fibrin alpha-chain at low ionic strengths and pH's, despite the replacement of the amino-terminal Gly by another aliphatic
amino acid Val.